ELA · CeTMad/ELA/2011
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A multicenter, randomized, placebo-controlled, triple-blind phase I/II clinical trial assessing the safety, feasibility and efficacy trend of intravenous therapy with three doses of autologous adipose-derived mesenchymal cells in patients with moderate to severe amyotrophic lateral sclerosis (ALS). EudraCT: 2011-006254-85.
Sponsor: FPS
Phase: II
Area: Neuromuscular disorders